Fisetin For Women: The Senolytic And Its Applications In Female Aging
Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS
Fisetin, a potent senolytic flavonoid, selectively eliminates senescent cells, offering women benefits for healthy aging by reducing inflammation, improving skin health, and supporting cognitive function.
# Women and Fisetin: The Senolytic and Its Applications in Female Aging
Fisetin: A Targeted Approach to Cellular Senescence
A key driver of aging and age-related diseases is the accumulation of senescent cells—often referred to as \"zombie cells.\" These cells cease to divide but remain metabolically active, secreting a pro-inflammatory cocktail of molecules known as the Senescence-Associated Secretory Phenotype (SASP). SASP contributes to chronic low-grade inflammation (inflammaging), tissue dysfunction, and accelerates the aging process. Fisetin, a natural flavonoid found in fruits like strawberries, apples, and persimmons, has emerged as a potent senolytic agent, capable of selectively eliminating these detrimental senescent cells. Its targeted action holds particular promise for addressing female-specific aspects of aging.
Fisetin\"s Benefits for Female Aging
Clinical Context and Practical Takeaways
For clinicians, fisetin represents a novel and targeted approach to healthy aging, particularly for women. While research is still in its early stages, its senolytic properties offer a unique mechanism to combat age-related dysfunction. Dietary sources of fisetin, such as strawberries, should be encouraged. For supplementation, typical doses used in research range from 100-500 mg/day, often in pulsed regimens. It\"s important to counsel patients that fisetin should be integrated into a comprehensive healthy aging strategy that includes diet, exercise, and other lifestyle interventions. As with any new supplement, consultation with a healthcare provider is recommended, especially for women with pre-existing conditions or those on medication.
Future Directions
Future research will focus on large-scale, placebo-controlled clinical trials to confirm fisetin\"s senolytic efficacy and clinical benefits in women, particularly concerning skin health, cognitive function, and bone density. Elucidating optimal dosing strategies, long-term safety, and its synergistic effects with other longevity compounds will be crucial for its widespread adoption in female healthy aging protocols.
References
[1] Zhu, Y., et al. (2015). New agents that target senescent cells: the flavone fisetin and the galacto-oligosaccharides. Aging Cell, 14(4), 644-651.
[2] Yousefzadeh, M. J., et al. (2018). Fisetin is a senotherapeutic that extends healthspan and lifespan. EBioMedicine, 36, 18-28.
[3] Kim, S. R., et al. (2018). Fisetin inhibits UVB-induced photoaging by regulating AP-1 and Nrf2/ARE pathways in human dermal fibroblasts. Journal of Dermatological Science, 91(1), 78-86.
[4] Currais, A., et al. (2018). Fisetin reduces the impact of aging on behavior and pathology in the rapidly aging SAMP8 mouse. Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 73(3), 299-307.
[5] Farr, J. N., et al. (2017). Fisetin reduces senescent cell burden in aging mice. Aging Cell, 16(5), 1018-1026.